Amedisys, Inc.

NasdaqGS:AMED 주식 보고서

시가총액: US$3.0b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Amedisys 관리

관리 기준 확인 1/4

Amedisys' CEO는 Richard Ashworth, Apr2023 에 임명되었습니다 의 임기는 1.17 년입니다. 총 연간 보상은 $ 16.97M, 4.1% 로 구성됩니다. 4.1% 급여 및 95.9% 보너스(회사 주식 및 옵션 포함). 는 $ 2.64M 가치에 해당하는 회사 주식의 0.088% 직접 소유합니다. 2.64M. 경영진과 이사회의 평균 재임 기간은 각각 1.8 년과 4.6 년입니다.

주요 정보

Richard Ashworth

최고 경영자

US$17.0m

총 보상

CEO 급여 비율4.1%
CEO 임기1.3yrs
CEO 소유권0.09%
경영진 평균 재임 기간1.8yrs
이사회 평균 재임 기간4.7yrs

최근 관리 업데이트

Recent updates

Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 41% Discount?

Apr 10
Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 41% Discount?

Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?

Feb 25
Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?

Amedisys (NASDAQ:AMED) Will Be Hoping To Turn Its Returns On Capital Around

Feb 10
Amedisys (NASDAQ:AMED) Will Be Hoping To Turn Its Returns On Capital Around

At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

Jan 03
At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Dec 16
A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal

Nov 12
Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal

Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?

Sep 19
Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?

An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued

Sep 04
An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued

Amedisys: ROIC, Tangible Book Value Each Softening

Aug 24

Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement

Aug 04
Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement

Amedisys profit beats by $0.24, revenue misses by $25.23M, 2022 guidance below estimates

Jul 27

We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt

Jul 20
We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt

At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

Jun 04
At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled

May 05
Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled

Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?

Apr 20
Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?

Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?

Apr 06
Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?

Is Amedisys (NASDAQ:AMED) A Risky Investment?

Feb 20
Is Amedisys (NASDAQ:AMED) A Risky Investment?

Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue

Jan 19
Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue

Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

Dec 03
Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely

Nov 18
These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely

Amedisys (NASDAQ:AMED) Could Easily Take On More Debt

Aug 18
Amedisys (NASDAQ:AMED) Could Easily Take On More Debt

Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Jul 23
Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Amedisys: Strategic Contessa Acquisition Underpins The Home Healthcare Growth Opportunity

Jul 18

Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive

Jun 28
Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive

It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package

Jun 02
It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package

Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

May 24
Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

CEO 보상 분석

Richard Ashworth 의 보수는 Amedisys 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$21m

Dec 31 2023US$17mUS$692k

-US$10m

보상 대 시장: Richard 의 총 보상 ($USD 16.97M )은 US 시장( $USD 6.80M ).

보상과 수익: Richard 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.


CEO

Richard Ashworth (49 yo)

1.3yrs

테뉴어

US$16,974,025

보상

Mr. Richard M. Ashworth served as Director at Tivity Health, Inc. since June 1, 2020 until April 2023 and had been its President since June 1, 2020 and served as its Chief Executive Officer since June 1, 2...


리더십 팀

이름위치테뉴어보상소유권
Richard Ashworth
President1.3yrsUS$16.97m0.088%
$ 2.6m
Scott Ginn
Executive VP6.8yrsUS$4.45m0.077%
$ 2.3m
Michael North
Chief Information Officer7.7yrsUS$1.55m0.033%
$ 977.6k
Denise Bohnert
Chief Compliance Officer4.8yrsUS$1.28m데이터 없음
Nick Muscato
Chief Strategy Officerno dataUS$1.37m0.0061%
$ 182.7k
Allyson Guidroz
Chief Accounting Officer & Principal Accounting Officerless than a year데이터 없음0.0050%
$ 149.7k
Pete Hartley
CTO & Senior VP of Business Operations Systemsno data데이터 없음데이터 없음
Jennifer Griffin
Senior VP1.8yrs데이터 없음데이터 없음
Kendra Kimmons
VP of Marketing & Communications & Media Relationsno data데이터 없음데이터 없음
Caitlin Franklin
Acting Chief People Officerless than a year데이터 없음데이터 없음
Francis Mayer
Senior Vice President of Developmentno data데이터 없음데이터 없음

1.8yrs

평균 재임 기간

49yo

평균 연령

경험이 풍부한 관리: AMED 의 관리팀은 경험 (평균 재직 기간 1.8 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Richard Ashworth
President1.3yrsUS$16.97m0.088%
$ 2.6m
Paul Kusserow
Chairman9.6yrsUS$4.00m1.34%
$ 40.1m
Bruce Perkins
Independent Director9.3yrsUS$267.62k0.063%
$ 1.9m
Vickie Capps
Independent Director4.7yrsUS$277.62k0.020%
$ 592.1k
Molly Coye
Independent Director4.7yrsUS$267.62k0.017%
$ 500.4k
Julie Klapstein
Lead Independent DIrector8.3yrsUS$282.62k0.039%
$ 1.2m
Jeffrey Rideout
Independent Director8.3yrsUS$267.62k0.018%
$ 547.8k
Teresa Kline
Independent Director4.7yrsUS$272.62k0.020%
$ 592.1k
Ivanetta Samuels
Independent Director3.6yrsUS$252.62k0.013%
$ 388.5k

4.7yrs

평균 재임 기간

63yo

평균 연령

경험이 풍부한 이사회: AMED 의 이사회경험(평균 재직 기간 4.6 년)으로 간주됩니다.